SARS-CoV-2 infections in infants in Haiti 2020-2021; evidence from a seroepidemiological cohort아이티 2020-2021년 유아의 SARS-CoV-2 감염; 혈청 역학 코호트의 증거Observational Study Published on 2022-08-252022-09-11 Journal: PLoS ONE [Category] SARS, 임상, 진단, 치료기술, 치료제, [키워드] age antibody Blood children Cohort collected country Course covariate COVID-19 case DBS sample DBS samples detectable ELISA estimate Evidence Frequency Haiti hazard highest independent independent of Infant Infants Infection initial less longitudinal samples over pandemic Patient patient age pregnant women prospective observational cohort Receptor binding domain reported Retrospective analysis S1 protein sampling SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 S1 protein Seroconversion seroconversion rates serological response seropositive seropositive sample subsequent tested the SARS-CoV-2 [DOI] 10.1371/journal.pone.0273482 PMC 바로가기 [Article Type] Observational Study
Two-years antibody responses following SARS-CoV-2 infection in humans: A study protocol인간에서 SARS-CoV-2 감염 후 2년 항체 반응: 연구 프로토콜Article Published on 2022-08-162022-09-12 Journal: PLoS ONE [Category] SARS, 진단, [키워드] 95% confidence interval anti-SARS-CoV-2 antibody antibody kinetics Antibody Response association Characteristics Clinical data CMIA Cohort collected Community control group controls cumulative determine disease severity IgG IgM Indonesia infected patient Infection information Kaplan-Meier method Logistic regression non-infected observé Odds ratio Patient protective factor Protein RBD of SARS-CoV-2 recruit risk risk factor RT-PCR SARS CoV-2 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 patient seroconversion rates serum sample Study protocol tested the SARS-CoV-2 Transmission used to calculate variables [DOI] 10.1371/journal.pone.0272690 PMC 바로가기 [Article Type] Article
Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort studyArticle Published on 2022-08-122022-11-15 Journal: Frontiers in Immunology [Category] SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome anti-SARS-CoV-2 antibody antibody Characteristics chronic respiratory disease CoronaVac coronavirus coronavirus disease COVID-19 COVID-19 vaccine COVID-19 vaccines delta variant detectable disease Dynamic changes Effectiveness elicited Emergency use IgM response immunogenicity Immunoglobulin inactivated Inactivated vaccine investigated live SARS-CoV-2 neutralizing antibody nucleocapsid Older age pandemic persistence persistence. population-based cohort Protective Protein pseudovirus recipient responses SARS-CoV-2 SARS-CoV-2 variants SARS-CoV-2-specific antibodies seroconversion rates seroconverted significantly lower the SARS-CoV-2 vaccination Vaccine vaccine dose wildtype [DOI] 10.3389/fimmu.2022.939311 PMC 바로가기
Immune responses to SARS-CoV-2 vaccination in multiple sclerosis: a systematic review/meta-analysis다발성 경화증에서 SARS-CoV-2 백신 접종에 대한 면역 반응: 체계적인 검토/메타 분석Review Published on 2022-08-012022-09-11 Journal: Annals of Clinical and Translational Neurology [Category] COVID19(2023년), SARS, 치료기술, [키워드] Acetate Affect Alemtuzumab anti-CD20 Antibody detection Antibody Response Antibody responses Antibody testing applied CD20 cellular response Cellular responses Cladribine demonstrated dimethyl fumarate Epidemiology fumarate Glatiramer Glatiramer acetate Google Scholar HCs healthy control immune response Immunity inactivated independent interferon Interferon-beta mAb mAbs Meta-analysis meta-analysis and systematic review monoclonal antibody MOOSE mRNA mRNA vaccine mRNA vaccines multivariate logistic regression multivariate logistic regression model Natalizumab not affect observational studies observational study Odds ratio Patient positive predict response SARS-CoV-2 infections SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines searched seroconversion rate seroconversion rates sphingosine-1-phosphate systematic review T cell T cell response T-cell Response T-cell responses Teriflunomide therapy Vaccine vaccine immunity vaccine response Vaccines vector virus [DOI] 10.1002/acn3.51628 PMC 바로가기 [Article Type] Review
Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study말초 림프구 하위 집합 수는 암 환자에서 SARS-CoV-2 mRNA-BNT162b2 백신 후 항체 반응을 예측합니다: Vax-On-Profile 연구 결과Article Published on 2022-07-012022-09-11 Journal: International immunopharmacology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Adaptive immune response Analysis anti-RBD Antibody Response Antibody titer Antibody titers B cell B cells Cancer cancer patient Cancer patients Chemotherapy circulating collected correlation Corticosteroid corticosteroid therapy COVID-19 COVID-19 vaccination Cytotoxic chemotherapy defined Flow cytometry analysis helper cell humoral humoral immunogenicity Humoral response IgG IgG antibodies IgG antibody IgG titer immunosuppressive indicated interactions linear correlation lymphocyte Lymphocyte subset Lymphocyte subsets mRNA Multivariate analysis Negative predictive value Occurrence Patient peripheral Peripheral blood positive positive linear correlation predict Predictive Predictive value Protein Quantitative RBD receiving Receptor-binding domain Result ROC Curve SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV-2 vaccine seroconversion rate seroconversion rates seroconversion response serologic testing Serologically shown significantly spike Spike protein subgroups subpopulations subset symptomatic infections T helper T helper cell T helper cell. tested the receptor-binding domain the SARS-CoV-2 treated Univariate analysis vaccination efficacy Vaccine [DOI] 10.1016/j.intimp.2022.108774 PMC 바로가기 [Article Type] Article
Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patients리툭시맙 치료 환자에서 COVID-19 백신 접종에 대한 체액 반응 장애의 위험 요인Observational Study Published on 2022-06-282022-09-11 Journal: Rheumatology (Oxford, England) [Category] COVID19(2023년), MERS, SARS, 바이오마커, 임상, 진단, 치료기술, [키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analysis antibody antibody levels Antibody Response B cell B cells CD19 Characteristics chronic inflammatory rheumatic disorder consecutive patient consecutive patients coronavirus coronavirus disease Coronavirus disease 2019 correlated COVID-19 COVID-19 vaccination cut-off value demographics detectable disease Factor humoral Humoral response identify IgG antibody independent Inflammatory monitoring monotherapy MTX multivariate multivariate analyses negative Odds ratio Patient patients produced receiving recruited respiratory rheumatic disease Rheumatic diseases rituximab RTX SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 vaccination seroconversion rate seroconversion rates serology Seropositivity severe acute respiratory syndrome Coronavirus Spike protein Spike proteins therapy two-dose regimen undetectable usual care vaccination vaccination. were measured [DOI] 10.1093/rheumatology/keab815 PMC 바로가기 [Article Type] Observational Study
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort studyHIV 감염자에 대한 CoronaVac의 안전성 및 면역원성: 전향적 코호트 연구Article Published on 2022-05-012022-09-12 Journal: The Lancet. HIV [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] adjusted age and sex antiretroviral baseline Brazil CD4 CD4 cell CD4 count Cell Complete Concentration concerning control group CoronaVac COVID-19 vaccine delayed response geometric mean titre highlight HIV HIV/AIDS IgG immunogenicity Immunosuppression IMPROVE inactivated increase in independent intramuscularly investigated IQR less median multivariable model NAb activity neutralising antibody outpatient clinic participant people with HIV positive prospective cohort study recruited reduced reported Safety SARS-CoV-2 IgG SARS-CoV-2 vaccine second dose serious adverse reaction Seroconversion seroconversion rates titre two-dose regimen university vaccination Vaccine vaccine administration vaccine dose vaccine immunogenicity Vaccines Viral load was collected with HIV [DOI] 10.1016/S2352-3018(22)00033-9 PMC 바로가기 [Article Type] Article
Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic ReviewRandomized Controlled Trial Published on 2022-05-012022-10-04 Journal: Value in health : the journal of the International [Category] 비임상, 유전자 메커니즘, 임상, [키워드] 6 hour acute respiratory syndrome adverse event adverse events all-cause mortality antibody conducted Control control arm control group Controlled trial coronavirus COVID-19 COVID-19 vaccine death disease dose elicited emergence evaluate examined fatigue females Fever for inclusion geometric mean titer GMT GMTs group headache highest immune response immunogenicity Immunoglobulin Infection local reaction Mild mRNA-1273 neutralizing antibody Pain pandemic Placebo postvaccination profiles Qualitative ranged reaction reported retrieved review Safety seroconversion rates severe adverse event subject systematic review the healthy tolerable vaccination Vaccine vaccine. Vaccines while [DOI] 10.1016/j.jval.2021.09.003 PMC 바로가기 [Article Type] Randomized Controlled Trial
The humoral response to SARS-COV-2 vaccines in MS patients: A case series exploring the impact of DMT, lymphocyte count, immunoglobulins, and vaccine type다발성경화증 환자에서 SARS-COV-2 백신에 대한 체액성 반응: DMT, 림프구 수, 면역글로불린 및 백신 유형의 영향을 탐구하는 사례 시리즈Article Published on 2022-05-012022-09-11 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Affect age antibody association B-cell case sery CD19 Cell Certain disease correlation COVID19 depleting detectable disease disease phenotype disorder DMT dose Exploratory analysis females fumarate Gender group humoral Humoral response Hypogammaglobulinemia immune response immunoglobulins immunological immunological characteristics lymphocyte Lymphocyte count lymphocyte counts lymphopenia Mild Multiple multiple sclerosis no differences Patient performed positive positive patient positive patients Quantitative response to vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV2 seroconversion rate seroconversion rates Spike protein subgroup subgroups tested the spike protein therapy vaccination vaccination. Vaccine vaccine response Vaccines variable verification [DOI] 10.1016/j.msard.2022.103785 PMC 바로가기 [Article Type] Article
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)면역매개염증질환(RESCUE)에서 DMARD 치료를 일시적으로 중단한 후 COVID-19 ChAdOx1nCov-19 및 BNT162b 백신에 대한 항체 반응Randomized Controlled Trial Published on 2022-05-012022-09-11 Journal: RMD Open [Category] COVID19(2023년), MERS, SARS, 임상, 진단, 치료기술, 치료제, [키워드] Adult patients Antibody Response Antibody responses antirheumatic agents AstraZeneca AZ vaccine baseline biologic BNT162b Control control group control groups controls COVID-19 csDMARD dose Final first and second dose first dose first vaccination group groups IgG Immune-mediated immunogenicity inflammatory disease Messenger RNA multicentre not significantly different Patient Pfizer Protein randomised randomised controlled trial registration number response S1/S2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV2 second dose second vaccination Seroconversion seroconversion rate seroconversion rates significantly lower the antibody response the mean therapy titre titres U/mL vaccination vaccination. Vaccine were measured [DOI] 10.1136/rmdopen-2022-002301 PMC 바로가기 [Article Type] Randomized Controlled Trial